双抗-话题@MedSci

#双抗#

81篇内容 | 3543人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1487228, encodeId=5573148e2281a, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。, objectType=article, longId=125160, objectId=e657125160d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e657125160d8, replyNumber=0, likeNumber=63, createdTime=2018-01-01, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e657125160d8, moduleTitle=Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e657125160d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487227, encodeId=40f7148e227bd, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=JAHA：支架和双抗血小板治疗时间的比较：手术操作者的经验是否会影响研究结果？, objectType=article, longId=124453, objectId=95d7124453eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95d7124453eb, replyNumber=0, likeNumber=70, createdTime=2017-12-25, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95d7124453eb, moduleTitle=JAHA：支架和双抗血小板治疗时间的比较：手术操作者的经验是否会影响研究结果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95d7124453eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487226, encodeId=423f148e226d6, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, objectType=article, longId=119427, objectId=a68511942e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a68511942e0c, replyNumber=0, likeNumber=131, createdTime=2017-11-11, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a68511942e0c, moduleTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a68511942e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487225, encodeId=30b7148e225ed, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Am Heart J：糖尿病ACS患者：普拉格雷 vs 氯吡格雷双抗方案, objectType=article, longId=107604, objectId=e0a310e60486, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0a310e60486, replyNumber=0, likeNumber=118, createdTime=2017-08-05, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0a310e60486, moduleTitle=Am Heart J：糖尿病ACS患者：普拉格雷 vs 氯吡格雷双抗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0a310e60486)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487224, encodeId=77cc148e224ac, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=SCI REP：轻微卒中或TIA患者接受双抗血小板治疗的益处受血压水平的影响！, objectType=article, longId=102721, objectId=14c6102e2123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14c6102e2123, replyNumber=0, likeNumber=85, createdTime=2017-06-22, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14c6102e2123, moduleTitle=SCI REP：轻微卒中或TIA患者接受双抗血小板治疗的益处受血压水平的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14c6102e2123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487223, encodeId=a3c1148e2235a, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Neurology：CHANCE研究：双抗治疗轻型卒中/TIA获益主要在前2周, objectType=article, longId=99130, objectId=151299130a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=151299130a6, replyNumber=0, likeNumber=70, createdTime=2017-05-20, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=151299130a6, moduleTitle=Neurology：CHANCE研究：双抗治疗轻型卒中/TIA获益主要在前2周, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=151299130a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487222, encodeId=226c148e2222d, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？, objectType=article, longId=95894, objectId=048995894e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048995894e0, replyNumber=0, likeNumber=63, createdTime=2017-04-16, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048995894e0, moduleTitle=Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=048995894e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487221, encodeId=6429148e221b5, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险, objectType=article, longId=94752, objectId=0c4d94e522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c4d94e522f, replyNumber=0, likeNumber=79, createdTime=2017-04-07, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c4d94e522f, moduleTitle=Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c4d94e522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487220, encodeId=0c57148e220bd, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=这部分人接受1年双抗治疗获益更大！, objectType=article, longId=90131, objectId=4c1990131ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c1990131ea, replyNumber=0, likeNumber=76, createdTime=2017-03-01, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c1990131ea, moduleTitle=这部分人接受1年双抗治疗获益更大！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c1990131ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487219, encodeId=38d1148e219b3, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, objectType=article, longId=78092, objectId=6164e8092e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6164e8092e7, replyNumber=0, likeNumber=47, createdTime=2016-09-23, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6164e8092e7, moduleTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6164e8092e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487218, encodeId=77f8148e218cd, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=JAMA：PCI术后1年，还需要继续双抗血小板治疗吗？, objectType=article, longId=66372, objectId=38bb663e27f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38bb663e27f, replyNumber=0, likeNumber=79, createdTime=2016-04-12, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38bb663e27f, moduleTitle=JAMA：PCI术后1年，还需要继续双抗血小板治疗吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38bb663e27f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487217, encodeId=b634148e2177a, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=一种双抗体疗法可治愈感染埃博拉的猴子, objectType=article, longId=64922, objectId=9ab364922af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ab364922af, replyNumber=0, likeNumber=73, createdTime=2016-03-18, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ab364922af, moduleTitle=一种双抗体疗法可治愈感染埃博拉的猴子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ab364922af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487216, encodeId=ff8e148e216dd, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=ESC 2015：延长双抗至4年并未减少心血管事件（OPTIDUAL研究）, objectType=article, longId=55668, objectId=1b805566879, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b805566879, replyNumber=0, likeNumber=75, createdTime=2015-09-03, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b805566879, moduleTitle=ESC 2015：延长双抗至4年并未减少心血管事件（OPTIDUAL研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b805566879)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487215, encodeId=1cf5148e21570, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多, objectType=article, longId=47676, objectId=de254e6765e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de254e6765e, replyNumber=0, likeNumber=78, createdTime=2015-03-05, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de254e6765e, moduleTitle=Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de254e6765e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487214, encodeId=4d3c148e21483, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=PCI术后双抗到底需多久？, objectType=article, longId=46069, objectId=889f4606903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=889f4606903, replyNumber=0, likeNumber=85, createdTime=2015-01-25, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=889f4606903, moduleTitle=PCI术后双抗到底需多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=889f4606903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487213, encodeId=f5cf148e213b2, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), objectType=article, longId=42882, objectId=28904288280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28904288280, replyNumber=0, likeNumber=68, createdTime=2014-11-21, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28904288280, moduleTitle=NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28904288280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487212, encodeId=73f3148e21224, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？, objectType=article, longId=42739, objectId=e6e342e396c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6e342e396c, replyNumber=0, likeNumber=82, createdTime=2014-11-20, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6e342e396c, moduleTitle=AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6e342e396c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487211, encodeId=0662148e211d4, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件, objectType=article, longId=36233, objectId=c4443623340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4443623340, replyNumber=0, likeNumber=72, createdTime=2014-06-12, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4443623340, moduleTitle=SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4443623340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487210, encodeId=8cb1148e21060, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Am J Cardiol：延长置入DES患者双抗治疗增出血风险, objectType=article, longId=34858, objectId=1fb334858e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fb334858e2, replyNumber=0, likeNumber=90, createdTime=2014-05-18, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fb334858e2, moduleTitle=Am J Cardiol：延长置入DES患者双抗治疗增出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fb334858e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487209, encodeId=74a7148e2091c, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=陈韵岱：介入术后双抗时程勿“一刀切”, objectType=article, longId=27955, objectId=2e142e955b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e142e955b9, replyNumber=0, likeNumber=80, createdTime=2013-12-14, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e142e955b9, moduleTitle=陈韵岱：介入术后双抗时程勿“一刀切”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e142e955b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

双抗

2020-05-29

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Blood：APRIL，BCMA和TACI双抗原靶向的嵌合型抗原受体，在多发性骨髓瘤中的应用前景。

2018-01-01

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

JAHA：支架和双抗血小板治疗时间的比较：手术操作者的经验是否会影响研究结果？

2017-12-25

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？

2017-11-11

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Am Heart J：糖尿病ACS患者：普拉格雷 vs 氯吡格雷双抗方案

2017-08-05

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

SCI REP：轻微卒中或TIA患者接受双抗血小板治疗的益处受血压水平的影响！

2017-06-22

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Neurology：CHANCE研究：双抗治疗轻型卒中/TIA获益主要在前2周

2017-05-20

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Cardiovasc Ther：西班牙急性冠脉综合征(ACS)后双抗治疗时间？

2017-04-16

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Heart：预先双抗治疗或增加经导管主动脉瓣置入术患者出血风险

2017-04-07

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

这部分人接受1年双抗治疗获益更大！

2017-03-01

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布

2016-09-23

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

JAMA：PCI术后1年，还需要继续双抗血小板治疗吗？

2016-04-12

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

一种双抗体疗法可治愈感染埃博拉的猴子

2016-03-18

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

ESC 2015：延长双抗至4年并未减少心血管事件（OPTIDUAL研究）

2015-09-03

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Eur Heart J：稳定性冠脉病患者长期双抗治疗不良事件增多

2015-03-05

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

PCI术后双抗到底需多久？

2015-01-25

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

NEJM：心脏支架术后采用双抗治疗，30个月优于12个月？(DAPT研究)

2014-11-21

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

AHA 2014：郭艺芳：冠脉药物支架术后双抗治疗需多久？

2014-11-20

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

SCAI 2014 ：血管内介入后双抗治疗未改变主要不良事件

2014-06-12

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Am J Cardiol：延长置入DES患者双抗治疗增出血风险

2014-05-18

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

陈韵岱：介入术后双抗时程勿“一刀切”

2013-12-14

科室
- - 订阅+
  - 更多科室
工具
服务